We have updated our Terms of Use.
Please read our new Privacy Statement before continuing.

Pill poison

22 September 2020 By Lauren Silva Laughlin

Paul Singer’s hedge fund amassed a 15% interest in Cubic, then offered to buy it. The transport and defense tech company responded with a poison pill, understandably on this occasion. Shareholders are hoping for a deal. But Elliott may have played its cards in the wrong order.

This content is for Subscribers only


Email a friend

Please complete the form below.

Required fields *


(Separate multiple email addresses with commas)